Richard Cunningham
Directeur Général chez TYME TECHNOLOGIES, INC.
Postes actifs de Richard Cunningham
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 24/11/2020 | - |
| Directeur Général | 24/11/2020 | - | |
| ANEBULO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/10/2023 | - |
| Directeur Général | 05/10/2023 | - | |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| President | - | - |
Historique de carrière de Richard Cunningham
Anciens postes connus de Richard Cunningham
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | 01/04/2020 | 01/11/2020 |
| Directeur Général | 01/11/2014 | 01/11/2020 | |
| President | 01/11/2014 | 01/11/2020 |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 4 |
| President | 2 |
Sectorielle
| Health Technology | 5 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Health Technology |
- Bourse
- Insiders
- Richard Cunningham
- Expérience
